Artivion Inc (AORT) Common Stock USD0.01

Sell:$37.04Buy:$37.06Price increased$0.18 (0.49%)

Prices delayed by at least 15 minutes
Sell:$37.04
Buy:$37.06
Change:Price increased$0.18 (0.49%)
Prices delayed by at least 15 minutes
Sell:$37.04
Buy:$37.06
Change:Price increased$0.18 (0.49%)
Prices delayed by at least 15 minutes

Company Information

About this company

Artivion, Inc. is engaged in manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments, which include Medical Devices and Preservation Services. The medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, aortic aneurysms, and dissections, and, to a lesser extent, other conditions in cardiac and vascular surgery. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products.

Key people

James Patrick Mackin
Chairman of the Board, President, Chief Executive Officer, Director
Robert C. Thomson
Vice President - Research & Development
Jeffrey H. Burbank
Lead Independent Director
Thomas F. Ackerman
Independent Director
Daniel J. Bevevino
Independent Director
Marna P. Borgstrom
Independent Director
James W. Bullock
Independent Director
Lance A. Berry
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Jean F. Holloway
Senior Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
John E. Davis
Senior Vice President - Global Sales and Marketing
Amy D. Horton
Chief Accounting Officer, Vice President
Florian Tyrs
Vice President - Global Operations
Matthew A. Getz
Vice President - Human Resources
Andrew M. Green
Vice President - Regulatory Affairs
Rochelle L. Maney
Vice President - Global Quality
Click to see more

Key facts

  • Shares in issue
    49.98m
  • EPIC
    AORT
  • ISIN
    US2289031005
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $1.88bn
  • Employees
    1,800
  • Exchange
    New York Stock Exchange
  • Index
    S&P 600 Small Cap, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.